Abstract Background Since December 2019, the newly emerged SARS-CoV-2 virus
continues to infect humans and many people died from severe Covid-19 during the last 2 …

The new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes the
coronavirus disease 2019 (COVID-19) has significantly altered people's way of life. Despite …

Nanobodies, single-domain antibodies derived from variable domain of camelid or shark
heavy-chain antibodies, have unique properties with small size, strong binding affinity, easy …

The infectious severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the
causative agent for coronavirus disease 2019 (COVID-19). Globally, there have been …

Global health and economy are deeply influenced by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) and its newly emerging variants. Nanobodies with nanometer …

Abstract COVID-19, coronavirus disease 2019, caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has become a pandemic. At the time of writing this …

In the last two years, the world encountered the SARS-CoV-2 virus, which is still dominating
the population due to the absence of a viable treatment. To eradicate the global pandemic …

Purpose The newly emerged coronavirus (SARS-CoV-2) continues to infect humans, and no
completely efficient treatment has yet been found. Antibody therapy is one way to control …

Preparing for the Future — Nanobodies for Covid-19? | New England Journal of Medicine Skip to
main content The New England Journal of Medicine homepage Advanced Search SEARCH …

Since December 2019, the SARS-CoV-2 has erupted on a large scale worldwide and
spread rapidly. Passive immunization of antibody-related molecules provides opportunities …